Updates are available Correction dated 2021-06-10
Click to view Correction: https://doi.org/10.1038/s41416-021-01451-5
-
Authors
Rominiyi, Ola https://orcid.org/0000-0002-9724-0224
Vanderlinden, Aurelie
Clenton, Susan Jane
Bridgewater, Caroline
Al-Tamimi, Yahia https://orcid.org/0000-0002-9014-2728
Collis, Spencer James https://orcid.org/0000-0002-7874-1891
- License Information
-
More Information
Article History
Received: 2 April 2020
Revised: 16 September 2020
Accepted: 5 October 2020
First Online: 4 November 2020
Change Date: 10 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-021-01451-5
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: O.R. and S.p.J.C. are recipients of an Inovitro™ system (on loan from Novocure) and take part in the annual Inovitro™ Users Meeting hosted by Novocure. The remaining authors declare no competing interests.
: O.R. and S.p.J.C. acknowledge funding support from the Royal College of Surgeons, Neurocare, Yorkshire’s Brain Tumour Charity (formerly BTRS) and The Brain Tumour Charity. O.R., S.p.J.C. and C.B. acknowledge funding support from Sheffield Hospitals Charity. O.R., A.V., Y.A.T. and S.p.J.C. are supported by the NIHR Sheffield Biomedical Research Centre/NIHR Sheffield Clinical Research Facility, and all the authors wish to acknowledge kind funding support to cover the costs of publication provided by the NIHR Sheffield Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
